Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies (PRP; PPP; BMAC)
Acetabular Labrum Tear, Femoro Acetabular Impingement, Chondral Defect
About this trial
This is an interventional treatment trial for Acetabular Labrum Tear focused on measuring Acetabular Labrum Tear, Femoro Acetabular Impingement, Chondral Defect, Bone Marrow Aspirate Concentrate, Chondrolabral Junction, Osteoarthritis, Hip Arthroscopy, BMAC
Eligibility Criteria
Inclusion Criteria: Age: > or equal to 18 years Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand & sign the informed consent document Exclusion Criteria: Non-English speaking (PROM surveys are only validated in English) Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies
Sites / Locations
- Massachusetts General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Bone marrow aspirate concentrate (BMAC)
Control
Patients randomly allocated to receive BMAC will undergo hip arthroscopy and will receive PRP/PPP/BMAC application through the PI's standardized method of harvest, processing, and application.
Patients allocated to the control cohort will receive standard of care hip arthroscopy without PRP/PPP/BMAC application.